tiprankstipranks
Trending News
More News >
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
US Market
Advertisement

Amneal Pharmaceuticals (AMRX) Ownership - Who Owns Amneal Pharmaceuticals?

Compare
547 Followers

Amneal Pharmaceuticals (AMRX) Ownership Overview

41.30%9.77%0.28%9.51%39.15%
41.30% Insiders
0.28% Other Institutional Investors
9.51% ETFs
39.15% Public Companies and
Individual Investors
The ownership structure of Amneal Pharmaceuticals (AMRX) stock is a mix of institutional, retail, and individual investors. Approximately 19.55% of the company’s stock is owned by Institutional Investors, 41.30% is owned by Insiders, and 39.15% is owned by Public Companies and Individual Investors.
The ownership structure of Amneal Pharmaceuticals (AMRX) stock is a mix of institutional, retail, and individual investors. Approximately 10.04% of the company’s stock is owned by Institutional Investors, 41.30% is owned by Insiders, and 9.51% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 12, 2025
xxxxxxxxxxxxx
$452537
May 19, 2025
xxxxxxxxxxxxx
$372481
May 13, 2025
xxxxxxxxxxxxx
$379500
Mar 17, 2025
xxxxxxxxxxxxx
$41750000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$423441
Mar 31, 2025
xxxxxxxxxxxxx
$1759800
Mar 31, 2025
xxxxxxxxxxxxx
$12604316

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
48,578,209Insider15.50%401,741,788
26,856,413Insider8.80%222,102,536
25,617,285Insider8.17%211,854,947
22,127,400Insider7.06%182,993,598
15,226,892Institution4.86%125,926,397
13,620,287Institution4.35%112,639,773
6,534,161Institution2.08%54,037,511
2,409,460Institution0.77%19,926,234
1,903,649Institution0.61%15,743,177
1,738,151Institution0.55%14,374,509

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
13,620,287Institution4.35%112,639,773
2,409,460Institution0.77%19,926,234
1,903,649Institution0.61%15,743,177
1,738,151Institution0.55%14,374,509
1,567,812Institution0.50%12,965,805
1,121,364Institution0.36%9,273,680
1,056,854Institution0.34%8,740,183
881,335Institution0.28%7,288,640
814,311Institution0.26%6,734,352
442,944Institution0.14%3,663,147

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,944,202Institution1.58%36,191,559
3,902,472Institution1.25%28,566,095
3,842,293Institution1.23%31,775,763
2,510,577Institution0.80%18,377,424
2,331,045Institution0.74%17,063,249
1,159,649Institution0.37%9,590,297
961,382Institution0.31%8,094,836
860,963Institution0.27%7,120,164
803,150Institution0.26%5,879,058
703,571Institution0.22%5,860,746

FAQ

Who Owns Amneal Pharmaceuticals Inc (AMRX)?
According to the latest TipRanks data, approximately 0.28% of the company's stock is held by institutional investors, 41.30% is held by insiders, and 39.15% is held by retail investors.
    What percentage of Amneal Pharmaceuticals Inc (AMRX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.28% of Amneal Pharmaceuticals Inc (AMRX) stock is held by institutional investors.
      What percentage of Amneal Pharmaceuticals Inc (AMRX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 39.15% of Amneal Pharmaceuticals Inc (AMRX) stock is held by retail investors.
        Who owns the most shares of Amneal Pharmaceuticals Inc (AMRX)?
        Tushar Bhikhubhai Patel owns the most shares of Amneal Pharmaceuticals Inc (AMRX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis